Bank Julius Baer & Co. Ltd, Zurich Invitae Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$26.09 - $40.4 $18,263 - $28,280	-700 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$33.06 - $56.93 $988,196 - $1.7 Million	-29,891 Reduced 97.71%	700 $27,000
Q4 2020 Feb 24, 2021	BUY	$39.09 - $57.4 $63,403 - $93,102	1,622 Added 5.6%	30,591 $1.28 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $1.13 Million - $1.66 Million	28,969 New	28,969 $1.28 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.